Table 2:
Adjusted* odds ratios of health care providers encouraging HPV vaccination, STI testing, and pelvic exam/Pap test use in relation to sexual orientation in a cohort of U.S. women and men (N=17,675)
| Women (N=15,572) |
Men (N=2,103) |
|
|---|---|---|
| OR (95% Cl) | OR (95% Cl) | |
| Encouraged to have HPV vaccine among women (N=9,462) and men (N=1,369)a | ||
| Sexual orientation | ||
| Completely heterosexual with no same-sex partners (ref) | 1.00 | 1.00 |
| Completely heterosexual with same-sex partners | 1.02 (0.94, 1.11) | 0.86 (0.37, 2.04) |
| Mostly heterosexual | 1.06 (1.03, 1.10) | 1.23 (0.97, 1.57) |
| Bisexual | 1.04 (0.97, 1.12) | 2.05 (1.33, 3.18) |
| Gay/Lesbian | 0.90 (0.80, 1.00) | 2.20 (1.77, 2.74) |
| HCP knows sexual orientation | 1.10 (1.06, 1.15) | 1.45 (1.19, 1.77) |
| Encouraged to have STI test among women (N=13,907) and men (N=1,930)a | ||
| Sexual orientation | ||
| Completely heterosexual with no same-sex partners (ref) | 1.00 | 1.00 |
| Completely heterosexual with same-sex partners | 1.27 (1.19, 1.36) | 1.12 (0.76, 1.66) |
| Mostly heterosexual | 1.27 (1.23, 1.32) | 1.15 (0.93, 1.41) |
| Bisexual | 1.30 (1.21, 1.40) | 1.81 (1.18, 2.76) |
| Gay/Lesbian | 1.01 (0.91, 1.12) | 2.32 (2.07, 2.60) |
| HCP knows sexual orientation | 1.17 (1.12, 1.23) | 1.53 (1.30, 1.80) |
| Encouraged to have pelvic exams/Pap tests among women (N=15,355)a | ||
| Sexual orientation | ||
| Completely heterosexual with no same-sex partners (ref) | 1.00 | -- |
| Completely heterosexual with same-sex partners | 1.00 (0.98, 1.02) | -- |
| Mostly heterosexual | 1.01 (1.00, 1.03) | -- |
| Bisexual | 1.01 (0.98, 1.04) | -- |
| Gay/Lesbian | 0.94 (0.91, 0.98) | -- |
| HCP knows sexual orientation | 1.05 (1.04, 1.07) | -- |